Nexxus Iberia acquires a majority shareholding in Skinclinic

Nexxus Iberia, a Spanish private equity firm, has closed the acquisition of a majority stake in Carmado S.L. (‘Skinclinic’), a company with more than 20 years of experience in the development and manufacture of professional cosmetic and personal care products. This transaction represents a strategic alliance between Nexxus Iberia and Cayetano Gutiérrez, founder and owner of Skinclinic, with the objective of supporting the national and international expansion of the company, while strengthening management capabilities.

Skinclinic, with headquarters in Alicante and a turnover of 12 million euros, is a reference in the Spanish market of advanced professional cosmetics and personal care, offering a wide range of high quality products for facial and body care, standing out for the innovation and quality of its formulations. With a team of more than 90 professionals and a proven position in aesthetic medicine and dermatology clinics, the company has more than 3,000 professional clients throughout the country, complementing its activity with the business lines of manufacturing for third parties and selling its products through its own website.

Cayetano Gutiérrez will continue at the helm of Skinclinic, leading his team and ensuring the continuity of its vision, values and excellence in formulation. To support the development of the company in the next stage, José Luis García-Pons, an executive with extensive experience in the cosmetics and food supplements industry, will join Skinclinic as CEO. At Nexxus, we believe that this fusion of talent will be a winning combination for the development of Skinclinic's future value creation plan.

Javier Onieva, Partner at Nexxus Iberia, commented: ‘We are partnering with Cayetano to support the business in the next phase of Skinclinic's internationalisation, accelerating the deployment of its model in markets such as Europe and Latin America. We strongly believe in the company's global potential, backed by a strong management team, a superior product offering and a differentiated brand value built by Cayetano and his team over many years of effort. Additionally, at Nexxus Iberia we have a particular interest in partnering with entrepreneurs in businesses operating in the health and wellness space, so Skinclinic is a perfect fit with our investment philosophy’.

Cayetano Gutiérrez, founder of Carmado states: ‘I am delighted to join forces with Nexxus Iberia, a partner that shares our vision of taking Skinclinic's excellence beyond our borders and that will be a guarantee of continuity in our way of doing things and serving our customers. This alliance will allow us to invest in innovation, strengthen our sales network, optimise production processes and, in general, reinforce the different teams of the company to continue offering high value products supported by an even closer service to our customers’.

With this operation, Nexxus Iberia reinforces its commitment to partner with entrepreneurs in companies with high growth potential, leaders in their niche markets and with international ambitions.

Skinclinic is the fourth investment of the recently launched Nexxus Iberia Fund II, which has total commitments of over €240 million. For Nexxus as a whole, this represents the sixteenth investment, including those made since its first fund, Nexxus Iberia Private Equity Fund I, and OFG Continuation Fund. The investment capitalises on the fund's expertise in the health and wellness sector following the completed investments in W Clinics (Dorsia), Bienzobas, Mercurius or Vivo Diagnóstico, the latter from its second fund. Other recent investments that complete the portfolio of Nexxus' second fund are Contenur and Marsanz.

Nexxus Iberia was advised on the transaction by Auren (M&A), Grant Thornton (legal advice), Deloitte (financial, legal, tax and labour due diligence advisor), Strategy& (commercial due diligence), Ramón y Cajal (financial legal advice), EY (ESG due diligence), Aon (insurance due diligence), while Garrigues (legal) and Clearwater International (M&A) advised the seller.

About Nexxus Iberia

Nexxus Iberia is a private equity fund manager founded in 2016 to support small and medium-sized Spanish and Portuguese companies to grow and expand internationally in Europe, Latin America and the US. The team is led by former 3i partners and Nexxus Capital partners.

Nexxus Iberia is the result of a partnership with Nexxus Capital, Mexico's leading alternative asset manager. Nexxus Capital has more than 25 years of experience investing in medium and large companies. Through eight funds, including growth equity, venture capital and private debt, Nexxus Capital has raised more than USD 1.6 billion and has supported more than 60 companies in Mexico, the US and the Iberian Peninsula through Nexxus Iberia. Nexxus Capital is the only manager in Latin America to carry out seven IPOs in public markets.

So far, Nexxus Iberia has raised commitments in excess of €500 million across the various investment vehicles under management. The latest fund, Nexxus II, has commitments of €241 million, with final closing in the first half of 2024, and has already completed the first three investments in Marsanz, Contenur and Vivo Diagnóstico. Nexxus Iberia's vision is to be the partner of reference for SME entrepreneurs in the Iberian market who are looking for a partner to support them in the international growth of their companies.
For more information about Nexxus Iberia, please visit www.nexxus-iberia.com, or contact: info@nexxus-iberia.com